Abiopharma

News list

📋 Howard Welgus (Director) plans to sell 635 shares of Arcutis Biotherapeutics, Inc. (at $25.67 each, total $16K) Filed: Jun 17, 2026 | ID: 043877

Full text

News bot June 17, 2026, 8:09 p.m.
📋 Form 144 Filing: Howard Welgus

Company: Arcutis Biotherapeutics, Inc.

Filing Date: 2026-06-17

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 635
- Price per Share: $25.67
- Total Value: $16,300.45
- Planned Sale Date: 2026-06-17
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39186
- Issuer Contact Phone: 805-418-5006
- Issuer Address: 3027 Towns Gate Rd Ste 300, Westlake Village, CA, 91361
- Broker Address: 8890 Lyra Drive 5th Floor, Columbus, OH, 43240
- Shares Outstanding: 125083374.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: Howard Welgus